Skip to content

Acute and Chronic Effects of Dynamic Apnea in Healthy Untrained Subjects

Acute and Chronic Effects of Dynamic Apnea in Healthy Untrained Subjects

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03095677
Acronym
APNEX
Enrollment
25
Registered
2017-03-30
Start date
2016-04-08
Completion date
2017-11-20
Last updated
2018-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Apnea

Keywords

dynamic apnea, muscle oxygenation, physical performance

Brief summary

The inclusion of short periods of apnea (several seconds) during exercise (i.e. dynamic apnea) induces a significant decrease in blood oxygenation and muscle tissue. To date, the immediate effects (acute apnea) of this decrease in the quantity of oxygen available at the muscle and brain level are poorly understood. Moreover, a physical training during which these short periods of apnea (chronic apnea) would be included could lead to physiological adaptations and to improvement in physical performance similar to those obtained during altitude training. The purpose of this study is to evaluate the effects of acute dynamic apnea on metabolism.

Interventions

OTHERProgram of training with exercises including apnea

16 training session on cycle ergometry with exercises including apneas.

OTHERProgram of training with exercises without apnea

16 training session on cycle ergometry with exercises without apnea

Sponsors

Laboratoire de Complexité, Innovation et Activités Motrices et Sportives
CollaboratorUNKNOWN
Centre Hospitalier Régional d'Orléans
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* The cutaneous thickness at the vastus lateralis level lower than 1.5 cm to obtain the reliable muscle oxygenation measurement * Subjects will have to sign the inform consent before the beginning of the study

Exclusion criteria

* Contraindications to regular physical exercise practice * To practice an endurance sport more than 1h/week * Regular practice of apnea * Chronic use of cannabis and/or alcohol * Cardiac or metabolic pathology * Asthma and/or bronchodilatator treatment * ECG abnormality at rest * Regular consumption of tobacco

Design outcomes

Primary

MeasureTime frameDescription
Spectometry to measure hemoglobin12 weeksMeasurement of oxygenation
Jaeger debimeter system to measure of peak oxygen3 weeksMeasurement of oxygen consumptiom
Measurement of arterial saturation in dioxygen3 weeksMeasurement by ear blood micro-sample
Spectometry to measure hemoglobin rate3 weeksMeasurement of oxygenation
Wingate test to measure maximum consumption of dioxygen3 weeksMeasurement of aerobic performance
Measurement of hormonal markers3 weeksMeasurement of Dehydroepiandrostenedione (DHEA)

Secondary

MeasureTime frameDescription
Borg scale to measure penibility of the effortweek 3
Cardiac frequency3 weeksmeasurement with a 12 lead - Electrocardiogamm

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026